Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > The mostly fools

<< Previous

Bullboard Posts

Next >>

Comment by Sciotoon May 17, 2021 7:00am

121 Views

Post# 33212602

RE:RE:RE:RE:The mostly fools

It is the company's duty to have accurate, current information explaining what we do, what we sell, and where we are going. From the most sophisticated investment firm or analysts to basic social media actors, the company needs to educate and not leave it to chance for people to figure us out. Our IR efforts are ineffective and their overhaul needs to be a top priority over next 12 months.

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it